Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/22/13 → 6/20/15 |
Funding
- Quintiles, Inc. (Prot #PCYC-1117-CA // Prot #PCYC-1117-CA)
- Pharmacyclics, Inc. (Prot #PCYC-1117-CA // Prot #PCYC-1117-CA)
Prot #PCYC-1117-CA: An Open-label, Single arm, Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma with 17p Deletion
- Ma, Shuo (PD/PI)
Project: Research project